subscribeSubscribe
US WorldMeds Reaches Agreement With Walgreens

US WorldMeds Reaches Agreement With Walgreens
PRNEWSWIRE
31 Aug 2021
Share Share
US WorldMeds Announces Partnership With FEMA And Healthcare ReadY

US WorldMeds Announces Partnership With FEMA And Healthcare ReadY
PRNEWSWIRE
08 Jul 2020
Share Share
Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival

Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival
Angus Liu FIERCE PHARMA
21 Nov 2018
Share Share
Valeant signs on to hawk opioid withdrawal drug Lucemyra

Valeant signs on to hawk opioid withdrawal drug Lucemyra
Carly Helfand FIERCE PHARMA
29 Jun 2018
Share Share
Catalent-made Lucemyra wins US FDA approval for opioid withdrawal

Catalent-made Lucemyra wins US FDA approval for opioid withdrawal
Flora Southey IN PHARMATECHNOLOGIST
25 May 2018
Share Share
FDA approves first drug to ease symptoms of opioid withdrawal

FDA approves first drug to ease symptoms of opioid withdrawal
Angus Liu FIERCEPHARMA
18 May 2018
Share Share
FDA approves first non-opioid to treat withdrawal symptoms in adults

FDA approves first non-opioid to treat withdrawal symptoms in adults
B. Meiling ENDPTS
18 May 2018
Share Share
The first drug for opioid withdrawal has gotten the green light

The first drug for opioid withdrawal has gotten the green light
ERIN BRODWIN BUSINESS INSIDER
17 May 2018
Share Share
US WorldMeds’ Lucemyra receives US FDA approval for opioid withdrawal symptoms

US WorldMeds’ Lucemyra receives US FDA approval for opioid withdrawal symptoms
PHARMAIZ
17 May 2018
Share Share
FDA Approves US WorldMeds` LUCEMYRA™ (lofexidine) After Priority Review

FDA Approves US WorldMeds` LUCEMYRA™ (lofexidine) After Priority Review
PR NEWSWIRE
16 May 2018
Share Share